Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 2

Results: 25

Development of nomograms to predict therapeutic response and prognosis of non-small cell lung cancer patients treated with anti-PD-1 antibody.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 533, doi. 10.1007/s00262-020-02710-9

By:

Yuan, Shijin;
Xia, Yan;
Shen, Lihong;
Ye, Liuqing;
Li, Lisha;
Chen, Lifen;
Xie, Xinyou;
Lou, Haizhou;
Zhang, Jun

Publication type:

Article

Curdlan, zymosan and a yeast-derived β-glucan reshape tumor-associated macrophages into producers of inflammatory chemo-attractants.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 547, doi. 10.1007/s00262-020-02707-4

By:

de Graaff, Priscilla;
Berrevoets, Cor;
Rӧsch, Christiane;
Schols, Henk A.;
Verhoef, Kees;
Wichers, Harry J.;
Debets, Reno;
Govers, Coen

Publication type:

Article

T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 509, doi. 10.1007/s00262-020-02705-6

By:

Akiyoshi, Takashi;
Gotoh, Osamu;
Tanaka, Norio;
Kiyotani, Kazuma;
Yamamoto, Noriko;
Ueno, Masashi;
Fukunaga, Yosuke;
Mori, Seiichi

Publication type:

Article

Immunogenic necroptosis in the anti-tumor photodynamic action of BAM-SiPc, a silicon(IV) phthalocyanine-based photosensitizer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 485, doi. 10.1007/s00262-020-02700-x

By:

Zhang, Ying;
Cheung, Ying-Kit;
Ng, Dennis K. P.;
Fong, Wing-Ping

Publication type:

Article

Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 475, doi. 10.1007/s00262-020-02698-2

By:

Beasley, Georgia M.;
Therien, Aaron D.;
Holl, Eda K.;
Al-Rohil, Rami;
Selim, Maria Angelica;
Farrow, Nellie E.;
Pan, Liuliu;
Haynes, Premi;
Liang, Yan;
Tyler, Douglas S.;
Hanks, Brent A.;
Nair, Smita K.

Publication type:

Article

The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 497, doi. 10.1007/s00262-020-02697-3

By:

Liu, Qingqing;
Hua, Shixian;
Wang, Xinyi;
Chen, Feihong;
Gou, Shaohua

Publication type:

Article

Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 391, doi. 10.1007/s00262-020-02690-w

By:

Chen, Jenny Ling-Yu;
Pan, Chun-Kai;
Huang, Yu-Sen;
Tsai, Ching-Yi;
Wang, Chun-Wei;
Lin, Yu-Li;
Kuo, Sung-Hsin;
Shieh, Ming-Jium

Publication type:

Article

Tumor cell-derived autophagosomes (DRibbles)-activated B cells induce specific naïve CD8+ T cell response and exhibit antitumor effect.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 463, doi. 10.1007/s00262-020-02695-5

By:

Zhang, Tian-Yu;
Ren, Hong-Yan;
Pan, Ning;
Dong, Hui-Xia;
Zhao, Si-Min;
Wen, Zhi-Fa;
Wang, Xu-Ru;
Wang, Li-Xin

Publication type:

Article

Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 431, doi. 10.1007/s00262-020-02694-6

By:

Yun, Sumi;
Koh, Jiwon;
Nam, Soo Kyung;
Kwak, Yoonjin;
Ahn, Sang-Hoon;
Do Park, Joong;
Kim, Hyung-Ho;
Kim, Woo Ho;
Lee, Hye Seung

Publication type:

Article

Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 563, doi. 10.1007/s00262-020-02693-7

By:

Hasan Ali, Omar;
Berner, Fiamma;
Ackermann, Christoph Jakob;
Ring, Sandra Stephanie;
Moulin, Alexandre;
Müller, Joachim;
Markert, Eva;
Pop, Oltin Tiberiu;
Müller, Stefanie;
Diem, Stefan;
Hundsberger, Thomas;
Flatz, Lukas

Publication type:

Article

Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 417, doi. 10.1007/s00262-020-02691-9

By:

Liu, Li-Li;
Zhang, Shi-Wen;
Chao, Xue;
Wang, Chun-Hua;
Yang, Xia;
Zhang, Xin-Ke;
Wen, Yan-lin;
Yun, Jing-Ping;
Luo, Rong-Zhen

Publication type:

Article

The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 443, doi. 10.1007/s00262-020-02696-4

By:

Urakawa, Shinya;
Yamasaki, Makoto;
Makino, Tomoki;
Kurokawa, Yukinori;
Yamamoto, Kei;
Goto, Kumiko;
Haruna, Miya;
Hirata, Michinari;
Morimoto-Okazawa, Akiko;
Kawashima, Atsunari;
Iwahori, Kota;
Mizushima, Tsunekazu;
Sato, Eiichi;
Mori, Masaki;
Doki, Yuichiro;
Wada, Hisashi

Publication type:

Article

Expression pattern, regulation, and clinical significance of TOX in breast cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 349, doi. 10.1007/s00262-020-02689-3

By:

Arora, Mohit;
Kumari, Sarita;
Singh, Jay;
Chopra, Anita;
Chauhan, Shyam S.

Publication type:

Article

Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 405, doi. 10.1007/s00262-020-02688-4

By:

Amrein, M. A.;
Bührer, E. D.;
Amrein, M. L.;
Li, Q.;
Rothschild, S.;
Riether, C.;
Jaggi, R.;
Savic-Prince, S.;
Bubendorf, L.;
Gautschi, O.;
Ochsenbein, A. F.

Publication type:

Article

A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 337, doi. 10.1007/s00262-020-02686-6

By:

Ando, Kiyohiro;
Hamada, Kazuyuki;
Shida, Midori;
Ohkuma, Ryotaro;
Kubota, Yutaro;
Horiike, Atsushi;
Matsui, Hiroto;
Ishiguro, Tomoyuki;
Hirasawa, Yuya;
Ariizumi, Hirotsugu;
Watanabe, Makoto;
Onoue, Rie;
Tsurutani, Junji;
Yoshimura, Kiyoshi;
Tsunoda, Takuya;
Kobayashi, Shinichi;
Wada, Satoshi

Publication type:

Article

Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 377, doi. 10.1007/s00262-020-02685-7

By:

Hu, Zhi-Qiang;
Xin, Hao-Yang;
Luo, Chu-Bin;
Li, Jia;
Zhou, Zheng-Jun;
Zou, Ji-Xue;
Zhou, Shao-Lai

Publication type:

Article

Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 265, doi. 10.1007/s00262-020-02684-8

By:

Mori, Keiichiro;
Mostafaei, Hadi;
Miura, Noriyoshi;
Karakiewicz, Pierre I.;
Luzzago, Stefano;
Schmidinger, Manuela;
Bruchbacher, Andreas;
Pradere, Benjamin;
Egawa, Shin;
Shariat, Shahrokh F.

Publication type:

Article

Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 519, doi. 10.1007/s00262-020-02670-0

By:

Leary, Alexandra;
Genestie, Catherine;
Blanc-Durand, Félix;
Gouy, Sébastien;
Dunant, Ariane;
Maulard, Amandine;
Drusch, Françoise;
Cheaib, Bianca;
Michels, Judith;
Bentivegna, Enrica;
LeFormal, Audrey;
Mesnage, Soizick;
Morice, Philippe;
Pautier, Patricia;
Khairallah, Aya S.

Publication type:

Article

PD-L1+ lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 453, doi. 10.1007/s00262-020-02648-y

By:

Raniszewska, A.;
Vroman, H.;
Dumoulin, D.;
Cornelissen, R.;
Aerts, J. G. J. V.;
Domagała-Kulawik, J.

Publication type:

Article

Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 323, doi. 10.1007/s00262-020-02681-x

By:

Makowska, Anna;
Meier, Selina;
Shen, Lian;
Busson, Pierre;
Baloche, Valentin;
Kontny, Udo

Publication type:

Article

Identification of STXBP6-IRF1 positive feedback loop in regulation of PD-L1 in cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 275, doi. 10.1007/s00262-020-02678-6

By:

Liu, Yanbin;
Huang, Zhicong;
Wei, Yanli;
Zhang, Mingming;
Li, Xingzhi;
Yang, Shulan;
Wang, Haihe

Publication type:

Article

Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 289, doi. 10.1007/s00262-020-02676-8

By:

Min, Aung Kyi Thar;
Mimura, Kosaku;
Nakajima, Shotaro;
Okayama, Hirokazu;
Saito, Katsuharu;
Sakamoto, Wataru;
Fujita, Shotaro;
Endo, Hisahito;
Saito, Motonobu;
Saze, Zenichiro;
Momma, Tomoyuki;
Ohki, Shinji;
Kono, Koji

Publication type:

Article

B7-H3 is spliced by SRSF3 in colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 311, doi. 10.1007/s00262-020-02683-9

By:

Zhang, Chunxia;
Chen, Yinshuang;
Li, Fuchao;
Yang, Man;
Meng, Fanyi;
Zhang, Yawen;
Chen, Weichang;
Wang, Weipeng

Publication type:

Article

Improved survival in patients with thyroid function test abnormalities secondary to immune-checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 299, doi. 10.1007/s00262-020-02664-y

By:

Lima Ferreira, Joana;
Costa, Cláudia;
Marques, Bernardo;
Castro, Sofia;
Victor, Margarida;
Oliveira, Joana;
Santos, Ana Paula;
Sampaio, Inês Lucena;
Duarte, Hugo;
Marques, Ana Paula;
Torres, Isabel

Publication type:

Article

Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 365, doi. 10.1007/s00262-020-02679-5

By:

Wang, Yan;
Ni, Haiqing;
Zhou, Shuaixiang;
He, Kaijie;
Gao, Yarong;
Wu, Weiwei;
Wu, Min;
Wu, Zhihai;
Qiu, Xuan;
Zhou, Ying;
Chen, Bingliang;
Pan, Donghui;
Huang, Chenrong;
Li, Mingzhu;
Bian, Yicong;
Yang, Min;
Miao, Liyan;
Liu, Junjian

Publication type:

Article